Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony-stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblasts

Journal of Immunology

Volumn 156, Issue 5, 1996, Pages 1946-1953

  Noso, Norio ^a   Sticherling, Michael ^a   Bartels, Joachim ^a   Mallet, Anthony I ^b   Christophers, Enno ^a   Schröder, Jens Michael ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; HEPARIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PHORBOL ESTER; PHYTOHEMAGGLUTININ; RANTES; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATOPIC DERMATITIS; CHEMOTAXIS; DERMIS; EOSINOPHIL; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN PURIFICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

AMINO ACID SEQUENCE; CELLS, CULTURED; CHEMOTACTIC FACTORS, EOSINOPHIL; CHEMOTAXIS, LEUKOCYTE; CULTURE MEDIA; FIBROBLASTS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-1; MALE; MOLECULAR SEQUENCE DATA; RANTES; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030063189     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Leiferman, K. M. 1991 A current perspective on the role of eosinophils in dermatologic diseases J. Am. Acad Dermatol. 24:1101.
2. Schröder, J.-M., U. Mrowietz, E. Morita, and E Christophers. 1987. Purification and partial biochemical characterization of a human monocyte-derived neutrophil-activating peptide that lacks interleukin 1 activity. J. Immunol 139:3474.
3. Gronhoj-Larsen, C , A. O. Anderson, E. Apella, J. J Oppenheim, and K. Matsushima. 1989 The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243:1464.
4. Matsushima, K , C. G. Larsen, G Du Bois, and J. J. Oppenheim. 1989 Purification and characterization of a novel monocyte chemotactic and activating factor produced by human myelo-monocytic cell line. J. Exp. Med. 169:1485.
5. Taub, D. D., P. Proost, W. J. Murphy, M. Anven, D L. Long, and J. Van Damme 1995. Monocyte chemotactic protein-1 (MCP-1), -2 and -3 are chemotactic for human T lymphocytes. J. Clin. Invest 95:1370.
6. Leonard, E. J., and T. Yoshimura. 1990. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 11.97.
7. Schall, T. J., K. Bacon, K. J. Toy, and D V. Goeddel. 1991 Selective attraction of monocytes and T-lymphocytes of the memory phenotype by cytokine RANTES. Nature 347:669.
8. Kameyoshi, Y., A. Dörschner, A I Mallet, E. Christophers, and J.-M. Schröder. 1992. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med. 176:587.
9. Rot, A., M. Krieger, T Brunner, S. C. Bischoff, T. J. Schall, and C. A. Dahinden. 1992 RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176:1489.
10. Alam, R , S. Stafford, P. Forsythe, R Harrison, D Faubion, M. A. Lett-Brown, and I. A Grant. 1993. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 150:3442.
11. Dahinden, C. A., T. Geiser, T. Brunner, V. v. Tscharner, D Caput, P Ferrara, A. Minty, and M Baggiolini 1994. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J. Exp Med. 179:751.
12. Noso, N , P Proost, J Van Damme, and J.-M Schröder. 1994. Human monocyte chemotactic proteins-2 and -3 (MCP-2 and MCP-3) attract human eosinophils and desensitize the chemotactic responses towards RANTES. Biochem. Biophys Res Commun 200 1470.
13. Gärtner, I 1980. Separation of human eosinophils in density gradients of polyvinylpyrrolidone-coated silica gel (Percoll) Immunology 40:133.
14. Morita, E., J.-M. Schröder, and E Christophers 1990. Identification of a novel and highly potent eosinophil chemotactic lipid in human eosinophils treated with arachidonic acid J Immunol. 144:1893.
15. Schroder, J.-M., M. Sticherling, H.-H. Henneicke, W. C. Preissner, and E. Christophers. 1990. IL-1α or tumor necrosis factor-α stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J Immunol. 144:2223
16. Sticherling, M., M. Küpper, F. Koltrowitz, E Bornscheuer, R. Kulke, M. Klinger, D. Wilhelm, Y. Kameyoshi, E. Christophers, and J -M. Schroder. 1995. Detection of chemokine RANTES in stimulated human dermal fibroblasts. J Invest. Dermatol 105:585.
17. Kay, I , and A I Mallet. 1993 Use of an on-line liquid chromatography trapping column for the purification of protein samples prior to electrospray mass spectrometric analysis. Rapid Commun. Mass Spectrom. 7:744.
18. Wardlaw, A. J , R Moqbel, O Cromwell, and A. B. Kay 1986. Platelet-activating factor a potent chemotactic and chemokinetic factor for human eosinophils. J. Clin. Invest 78.1701.
19. Schwenk, U., E. Morita, R. Engel, and J.-M. Schroder 1992 Identification of 5-oxo-15-hydroxy-6,8,11,13-eicosatetraenoic acid as a novel and potent human eosinophil chemotactic eicosanoid. J. Biol. Chem 267:12482.
20. Powell, W S., D Chung, and S. Gravel 1995 5-oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration. J Immunol. 154:4123.
21. Schwenk, U., and J.-M. Schröder. 1995. 5-oxo-eicosanoids are potent eosinophil chemotactic factors. J. Biol. Chem. 270.15036.
22. Klinger, M. H. F., D. Wilhelm, S. Bubel, M. Sticherling, J.-M Schroder, and W Kühnel. 1995. Immunocytochemical localization of the chemokines RANTES and MIP-1α within human platelets and their release during storage. Int. Arch Allergy Appl Immunol. 107:541
23. Schall, T. J., J. Jongstia, B J. Dyer, J. Jorgensen, C. Clayberger, M. M. Davis, and A. M Krensky. 1988. A human T cell-specific molecule is a member of a new gene family. J Immunol 141:1018
24. Devergne, O , A. Marfaing-Koka, T. T Schall, M.-B. Leger-Ravet, M Sadick, M Peuchmaur, M.-C Crevon, T. Kim, P. Galanaud, and E Emilie 1994. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells J. Exp. Med. 179:1689.
25. Marfaing-Koka, A , O. Devergne, G. Gorgone, A. Portier, T. J. Schall, P. Galanaud, and D Emilie 1995. Regulation of the production of the RANTES chemokine by endothelial cells. J. Immunol. 154:1870.
26. Rathanaswami, P , M. Hachicha, M. Sadick, T. J. Schall, and S. R. Mc Coll. 1993. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. J. Biol Chem. 268:5834
27. Cebon, J., N. Nicola, M. Ward, I. Gardner, P Dempsey, J. Layton, U. Durhrsen, A W. Burgess, E. Nice, and G. Morstyn 1990. Granulocyte-macrophage colony stimulating factor from human lymphocytes, the effect of glycosylation on receptor binding and biological activity. J. Biol. Chem. 265:4483.
28. 2. J. Clin. Invest 77: 1857.
29. Kurihara, K., A. I Wardlaw, P. Maestrelle, I.-J. Tsai, and A. B. Kay 1988. IL-1, TL-2, TNFα, IFN-C, GM-CSF and PHA-stimulated supernatants have negligible eosinophil chemotactic activity compared with platelet activating factor (PAF). FASEB J. 2:6695a.
30. Sehmi, R., A. J. Wardlaw, O. Cromwell, K. Kurihara, P. Waltmann, and A B. Kay 1992. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 79:2952.
31. Her, E., J. Frazer, K. F. Austen, and W. F. Owen. 1991. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils J Clin. Invest. 88: 1982.
32. Owen, W. F , M E. Rothenberg, D S. Silberstein, J. C. Gasson, R. L. Stevens, K. F Austen, and R. J Soberman. 1987. Regulation of human eosinophil viability, density, and functional activation by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J. Exp. Med. 166:129.
33. Ebisawa, M., T. Yamada, C. Bickel, D. Klunk, and R. P Schleimer. 1994. Eosinophil transendothelial migration induced by cytokines III. Effect of the chemokine RANTES J. Immunol. 153:2153.